Chemoinformaics analysis of 6-O-isovaleryldihydrohelenalin
| Molecular Weight | 348.439 | nRot | 3 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 18 |
| Exact Molecular Weight | 348.194 | nRing | 3 |
| Solubility: LogS | -3.232 | nHRing | 1 |
| Solubility: LogP | 2.828 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 56.0802 |
| nHD | 0 | BPOL | 34.1658 |
| QED | 0.579 |
| Synth | 4.661 |
| Natural Product Likeliness | 2.603 |
| NR-PPAR-gamma | 0.06 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.336 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.636 |
| MDCK | 0.0000175 |
| BBB | 0.986 |
| PPB | 0.643056 |
| VDSS | 0.834 |
| FU | 0.342047 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.131 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.305 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.073 |
| CYP3a4-inh | 0.757 |
| CYP3a4-sub | 0.517 |
| CL | 17.207 |
| T12 | 0.308 |
| hERG | 0.001 |
| Ames | 0.01 |
| ROA | 0.871 |
| SkinSen | 0.034 |
| Carcinogencity | 0.746 |
| EI | 0.069 |
| Respiratory | 0.91 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.695918 |